Use of angiotensin-(1-9) or derivates thereof, use of vectors overexpressing the ACE2 enzyme that produces angiotensin-(1-9) for preparing medicaments useful for preventing, reverting, inhibiting and/or reducing hypertension and/or inducing vasodilation
Más información
| Fecha de publicación: | 2016 |
| Notas: | Grant patent 14/390,663US 2016 |